- Report
- February 2024
- 120 Pages
Global
From €4516EUR$4,750USD£3,873GBP
- Report
- January 2024
- 185 Pages
Global
From €4658EUR$4,900USD£3,996GBP
- Report
- August 2023
- 112 Pages
Global
From €4658EUR$4,900USD£3,996GBP
- Report
- March 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,384GBP
- Report
- January 2024
- 119 Pages
Global
From €4278EUR$4,500USD£3,669GBP
- Report
- March 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,384GBP
- Report
- July 2020
- 269 Pages
Global
From €3324EUR$3,497USD£2,852GBP
- Report
- March 2021
- 137 Pages
Global
From €4658EUR$4,900USD£3,996GBP
- Report
- May 2022
- 231 Pages
Global
From €4562EUR$4,799USD£3,913GBP
- Report
- May 2022
- 365 Pages
Global
From €4562EUR$4,799USD£3,913GBP
- Report
- May 2021
- 381 Pages
Global
From €4562EUR$4,799USD£3,913GBP
- Report
- April 2020
- 248 Pages
Global
From €4657EUR$4,899USD£3,995GBP
- Report
- November 2019
- 403 Pages
Global
From €4277EUR$4,499USD£3,669GBP
- Report
- April 2018
- 449 Pages
Global
From €3326EUR$3,499USD£2,853GBP
- Report
- October 2022
- 194 Pages
Global
From €4753EUR$5,000USD£4,077GBP
- Report
- April 2023
- 206 Pages
Global
From €6655EUR$7,000USD£5,708GBP
- Report
- February 2022
- 199 Pages
Global
From €4991EUR$5,250USD£4,281GBP
- Report
- September 2022
- 110 Pages
Global
From €5229EUR$5,500USD£4,485GBP
- Report
- August 2021
- 113 Pages
Global
From €2614EUR$2,750USD£2,242GBP
€5229EUR$5,500USD£4,485GBP
- Report
- June 2021
- 141 Pages
Global
From €2614EUR$2,750USD£2,242GBP
€5229EUR$5,500USD£4,485GBP
DNA vaccines are a type of genomics-based vaccine that uses genetic material from a virus or bacteria to stimulate an immune response. They are created by introducing a gene that codes for a specific antigen into a plasmid, which is then inserted into a host cell. The host cell then produces the antigen, which is then used to stimulate an immune response. DNA vaccines are considered to be safer than traditional vaccines, as they do not contain any live virus or bacteria. Additionally, they can be produced more quickly and cheaply than traditional vaccines.
DNA vaccines have been used to treat a variety of diseases, including influenza, malaria, and HIV. They have also been used to develop vaccines for cancer and other diseases. Recently, DNA vaccines have been used to develop vaccines for the prevention of infectious diseases, such as Zika virus and Ebola.
Companies in the DNA Vaccines market include Moderna, Inovio Pharmaceuticals, Novavax, and Transgene. Show Less Read more